title: Cardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells.
abstract: Patients suffering from heart failure as a result of myocardial infarction are in need of heart transplantation. Unfortunately the number of donor hearts is very low and therefore new therapies are subject of investigation. Cell transplantation therapy upon myocardial infarction is a very promising strategy to replace the dead myocardium with viable cardiomyocytes, smooth muscle cells and endothelial cells, thereby reducing scarring and improving cardiac performance. Despite promising results, resulting in reduced infarct size and improved cardiac function on short term, only a few cells survive the ischemic milieu and are retained in the heart, thereby minimizing long-term effects. Although new capillaries and cardiomyocytes are formed around the infarcted area, only a small percentage of the transplanted cells can be detected months after myocardial infarction. This suggests the stimulation of an endogenous regenerative capacity of the heart upon cell transplantation, resulting from release of growth factor, cytokine and other paracrine molecules by the progenitor cells--the so-called paracrine hypothesis. Here, we focus on a relative new component of paracrine signalling, i.e. exosomes. We are interested in the release and function of exosomes derived from cardiac progenitor cells and studied their effects on the migratory capacity of endothelial cells.
authors.affiliation: University Medical Center Utrecht, Laboratory of Experimental Cardiology, Utrecht, The Netherlands.
authors.forename: K R
authors.initials: KR
authors.lastname: Vrijsen
authors.forename: J P G
authors.initials: JP
authors.lastname: Sluijter
authors.forename: M W L
authors.initials: MW
authors.lastname: Schuchardt
authors.forename: B W M
authors.initials: BW
authors.lastname: van Balkom
authors.forename: W A
authors.initials: WA
authors.lastname: Noort
authors.forename: S A J
authors.initials: SA
authors.lastname: Chamuleau
authors.forename: P A F M
authors.initials: PA
authors.lastname: Doevendans
mesh_terms: D051926:Basigin / Q000378:metabolism; D002465:Cell Movement / Q000187:drug effects; D017077:Culture Media, Conditioned / Q000494:pharmacology; D042783:Endothelial Cells / Q000166:cytology* / Q000187:drug effects / Q000201:enzymology; D055354:Exosomes / Q000187:drug effects / Q000378:metabolism*; D006801:Humans; D020782:Matrix Metalloproteinases / Q000378:metabolism; D008954:Models, Biological; D032383:Myocytes, Cardiac / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects; D033581:Stem Cell Transplantation; D013234:Stem Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*
chemical_list: D017077:Culture Media, Conditioned; D051926:Basigin; D020782:Matrix Metalloproteinases
references.citation: Nat Rev Immunol. 2002 Aug;2(8):569-79
references.pmid: 12154376
references.citation: Nature. 2001 Apr 5;410(6829):701-5
references.pmid: 11287958
references.citation: Circulation. 2003 Feb 25;107(7):1024-32
references.pmid: 12600917
references.citation: Cell. 2006 Aug 25;126(4):663-76
references.pmid: 16904174
references.citation: Cardiovasc Res. 2005 Oct 1;68(1):136-43
references.pmid: 15963479
references.citation: Oncogene. 2004 Jan 29;23(4):956-63
references.pmid: 14749763
references.citation: Curr Protoc Cell Biol. 2006 Apr;Chapter 3:Unit 3.22
references.pmid: 18228490
references.citation: Nat Cell Biol. 2007 Jun;9(6):654-9
references.pmid: 17486113
references.citation: Neth Heart J. 2009 May;17(5):199-207
references.pmid: 19484156
references.citation: FASEB J. 2006 Apr;20(6):661-9
references.pmid: 16581974
references.citation: Neth Heart J. 2008 May;16(5):163-9
references.pmid: 18566670
references.citation: J Cell Biochem. 2008 Dec 1;105(5):1211-8
references.pmid: 18802920
references.citation: Am J Physiol Heart Circ Physiol. 2008 Oct;295(4):H1726-35
references.pmid: 18723770
references.citation: Circ Res. 2010 Mar 19;106(5):971-80
references.pmid: 20110532
references.citation: Science. 1998 Nov 6;282(5391):1145-7
references.pmid: 9804556
references.citation: Stem Cell Res. 2010 May;4(3):214-22
references.pmid: 20138817
references.citation: Cancer Res. 2005 Apr 15;65(8):3193-9
references.pmid: 15833850
references.citation: Stem Cell Res. 2007 Nov;1(2):138-49
references.pmid: 19383394
references.citation: Arch Intern Med. 2007 May 28;167(10):989-97
references.pmid: 17533201
references.citation: Cardiovasc Res. 2009 Aug 1;83(3):527-35
references.pmid: 19429921
references.citation: J Clin Invest. 1999 May;103(9):1237-41
references.pmid: 10225966
references.citation: Nature. 2008 Feb 21;451(7181):937-42
references.pmid: 18288183
references.citation: Nat Protoc. 2009;4(2):232-43
references.pmid: 19197267
references.citation: Circ Res. 2008 Nov 21;103(11):1204-19
references.pmid: 19028920
references.citation: Stem Cells. 2007 Jan;25(1):236-44
references.pmid: 16973829
references.citation: Circulation. 2010 Jan 19;121(2):293-305
references.pmid: 20048209
references.citation: Stem Cell Res. 2007 Nov;1(2):129-37
references.pmid: 19383393
references.citation: Curr Opin Organ Transplant. 2009 Oct;14(5):560-5
references.pmid: 19623073
references.citation: FASEB J. 2007 May;21(7):1345-57
references.pmid: 17284483
references.citation: J Mol Cell Cardiol. 2010 Jun;48(6):1215-24
references.pmid: 20064522